Test Price
2,800 AED✅ Home Collection Available
ERCC1 Gene Cerebrooculofacioskeletal Syndrome Type 4 (COFS4) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Platform.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed physicians.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This test detects pathogenic variants in the ERCC1 gene causing cerebrooculofacioskeletal syndrome type 4 (COFS4), a severe autosomal recessive dysmorphology disorder. It confirms the molecular diagnosis in clinically suspected individuals and enables familial carrier screening.
| Parameter | Our Test (COFS4 NGS) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | Next-Generation Sequencing (Illumina NovaSeq) – full gene analysis | Sanger Sequencing (exon-by-exon, limited throughput) |
| Diagnostic Precision | 99.9% sensitivity & 100% coverage of coding exons ±10 bp intronic boundaries | ~95% sensitivity; may miss deep intronic or large deletions |
| Turnaround Time | 3 to 4 Weeks (ISO-certified rapid reporting) | 5–6 Weeks |
| Concurrent Analysis | Simultaneous coverage of potential ERCC1 copy number changes | Not possible; requires additional MLPA |
Physician Insight & Safety Protocols
“As a clinician, I understand the immense anxiety families face while awaiting a precise genetic diagnosis. This ERCC1 test provides molecular clarity that can directly shape early interventions and long-term care planning. However, it is crucial to interpret the result within the full clinical picture, and I strongly advocate for a follow-up genetic counseling session to discuss inheritance risks and family options.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory
Do not discontinue any prescribed medication without first consulting your supervising physician. Results from genetic testing should be correlated with clinical findings and confirmed by a qualified genetic counselor.
Exclusion Criteria
- Failure to provide informed consent or refusal of genetic testing.
- Active bleeding disorder or severe coagulopathy risk unless blood sample can be safely obtained by a medical professional.
ER Red Flags (Seek Immediate Care): Acute respiratory distress, seizures, severe hypotonia, sudden loss of consciousness, failure to thrive with significant weight loss.
Patient FAQ & Clinical Guidance
1. What is the ERCC1 COFS4 genetic test and how does it help?
This test analyzes the entire coding region of the ERCC1 gene using Next-Generation Sequencing to detect mutations causing cerebrooculofacioskeletal syndrome type 4. A positive result confirms the diagnosis and enables tailored medical surveillance and family planning. Results are discussed in post-test counseling to address inheritance risks and carrier status.
2. How long do results take and what does the process involve?
Results are available within 3 to 4 weeks. A simple blood sample (or DNA/FTA card) is collected by our ISO-certified phlebotomy team. The DNA is extracted, enriched for the ERCC1 gene, and sequenced on a high-fidelity NGS platform. Bioinformatic analysis and expert clinical validation ensure every report meets DHA standards. You will receive a teleconsultation to explain the outcome and next steps.
3. Is home blood collection available across the UAE?
Yes, VIP Mobile Phlebotomy with temperature-controlled cold-chain is available daily from 8 AM to 11 PM across all Emirates including Dubai, Abu Dhabi, Sharjah, and the Northern Regions. Simply contact us on WhatsApp to schedule a visit. Direct insurance billing can be verified beforehand.
UAE Regulatory & Data Privacy Adherence
Legal Framework: This genetic test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted and stored in DHA-audited facilities. Consent is obtained per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Laboratory Accreditation: DNA Labs UAE is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139) and licensed by DHA under Facility License Number 1143.
Clinical & Logistical Metadata
| Test Name | ERCC1 Gene Cerebrooculofacioskeletal Syndrome Type 4 (COFS4) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Blood (EDTA), Extracted DNA, or Blood on FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene analysis |
| ICD-10-CM Code | Q87.1 (COFS4), Z14.8 (Carrier), Z31.5 (Genetic counseling) |
| LOINC Code | 81233-3 (ERCC1 gene full mutation analysis) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians